are included here for statistical analysis. (A) when using IC50 > 1 uM to define resistance to selumetinib, cell lines with concomitant LKB1 mutation (excluding silent mutation) have significantly higher chance of resistance (Fisher's exact test: p = 0.0138, two-tailed). (B) A direct comparison of IC50 between LKB1 wild type (including silent mutation) and mutant NSCLC cell lines. Whenever possible, for each cell line, the median value of reported IC50 was used for the Mann-Whitney nonparametric test. For cell lines only having a range of value, such as > x or < y uM, then x or y value was used for estimation (p = 0.01, two-tailed). (C and D) Growth inhibition assay of isogenic H460 and H157 cells. The isogenic cells with or without wild type LKB1 were incubated with different concentrations of selumetinib for 72 hrs. With the re-expression of LKB1, cells were more sensitive to selumetinib with lower IC50.
Only BRAF->MEK->ERK and PI3K->AKT->mTOR are shown here. ERK has been reported to induce inhibitory phosphorylation of LKB1 [26, 27] . However, it is still not clear whether there is a feed-forward loop from LKB1 to ERK, although others [28] and we did observe LKB1 inactivation results in attenuated p-ERK ( Figure 1 ). This attenuated p-ERK is suggestive of reduced dependency on MEK->ERK signaling pathway, and we speculated it might be the reason of resistance to MEK inhibitor selumetinib in KRAS mutant NSCLC cells harboring LKB1 mutation. Due to escape mechanism, MEK inhibition will normally activate mTOR signaling, warranting co-inhibition of mTOR to achieve maximal inhibitory effect. (B) This shows the function of phenformin under alternative LKB1 status. Phenformin targets mitochondria complex 1 and induces ATP depletion. When there is intact LKB1, a metabolic regulation through AMPK activation will ensue -this normally downregulates mTOR signaling and induces growth suppression, hence there is value to combine with MEK inhibition. In contrast, when LKB1 is mutated or inactivated, cells go directly to apoptosis due to the lack of functional metabolic regulation. In fact, others [11] and we have shown LKB1 inactivation dictates the sensitivity to phenformin in NSCLC cells (Figure 2 ). Based on these rationales, we proposed the combination of selumetinib and phenformin, and have demonstrated their potential synergy that is irrespective of LKB1 status. KRAS G12V WT [1] < 0.30 [2] Calu-6 KRAS Q61K WT [3] 0.32 [4] , 0.33 [2] , 1.0 [5] SK-LU-1 KRAS G12D WT [3] 0.5 [5] H2009 KRAS G12A WT [6, 7] 0.99 [4] H727 KRAS G12V WT [1] 0.01 [8] SW900 KRAS G12V WT [9] 0.28 [8] H1944 KRAS G13D K62N, K78N < 0.30 [2] A427 KRAS G12D Null [10, 11] 0.55 [2] H2122 KRAS G12C P281fs*6, deletion [10, 12] < 0.1 [5] , 1.0 [13] H2347 NRAS Q61R WT [10] 0.31 [4] , 0.5 [14] , < 1 [15] H2087 NRAS Q61K; BRAF L597V
WT [6, 16] < 0.1 [14] H1666 BRAF G466V V236fs*30 0.36 [8] Considered as resistant to selumetinib (IC50 > 1 μM) A549 KRAS G12S Q37* 0.8 [2] , > 1 [17] , 5 [18] , ~5 [15] , 6.3 [8] , ~10 [5] , >10 [19] H23 KRAS G12C W332* 1.5 [2] , >10 [19] H460 KRAS G12S Q37* 1.7 [2] , 9.6 [8] , > 10 [18] , > 10
H2122 KRAS G12C P281fs*6~3 [15] H1734 KRAS G13C M51fs*14 4.2 [2] H157 KRAS G12R Null [10, 11] 9.3 [8] , > 10 [19] HCC44 KRAS G12C M51I, 52 → 162 stop [10] ~1 0 [15] H1355 KRAS G13C R49L [6, 20] ~100 [15] H647 KRAS G13D Null [21] > 5.0 [2] , > 10 [5] H2887 KRAS G12V [6, 22, 23] WT [6] 38 [15] H1155 KRAS Q61H WT (silent: I46I, P281P) > 5.0 [2] H1395 BRAF G469A E57fs*7 > 140 [15] H1755 BRAF G469A P281fs*6 8.1 [8] Controversial results in literature Calu-1 KRAS G12C WT [12] < 0.2 [2] , > 1 [17] , ~130 [15] H358 KRAS G12C WT [12] 0.2 [19] , 0.5 [2] , 1.0 [17] , ~10 [15] , > 10 [8] H1299 NRAS Q61K WT [24, 25] < 0.01 [18] , ~0.3 [2] , < 0.5 [14] , > 10 [5] , > 10 [8] , > 120 [15] They all have mutations of either the RAS or RAF genes, and were tested with selumetinib. Unless specifically noted, all mutation profiles were confirmed in COSMIC database. Since COSMIC database does not report wild type (WT) genes, the wild type LKB1 status was confirmed through literature search. Numbers in parentheses correspond to the cited study.
